The latest cancer drugs news
Browsing: Cancer Drug News
ASCO GI: New drug combinations maintain quality of life for patients with colorectal and liver cancers
Patient-reported outcomes from two large studies show that quality of life is maintained longer with…
Free tool simplifies cancer research
Every cell contains a vast number of proteins, each of which has a specific function,…
IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women
The Queen Mary University of London, UK, professor leading an international breast cancer study says…
Pembrolizumab rejected by NICE as a first-line treatment for advanced head and neck cancer
NICE has rejected to recommendation of using pembrolizumab as a first-line therapy for patients with…
Investigational drugs block bone loss in mice receiving chemotherapy
Bone loss that can lead to osteoporosis and fractures is a major problem for cancer…
Nuclear radiologists ‘outsmart’ prostate cancer with an apparently ineffective drug
When a non-scientist tries to imagine a scientist, the image that often arises is one…
FDA approves avapritinib for gastrointestinal stromal tumour with a rare mutation
The Food and Drug Administration has approved avapritinib for adults with unresectable or metastatic gastrointestinal…
Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice
Exposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggressive…
Breast cancer preventive effects of anastrozole persist long after stopping treatment
Breast cancer incidence among post menopausal women at high risk for developing the disease continued…
Addition of S-1 to post-operative endocrine therapy improves outcomes for patients with hormone receptor-positive, HER2-negative breast cancer
A post-operative combination of S-1, an oral fluoropyrimidine-based drug, with endocrine therapy significantly increased invasive…